We are live on ! Find out more
MCM

McMillion Capital Management Portfolio holdings

AUM $112M
1-Year Est. Return 22.02%
This Fund
S&P 500
This Quarter Est. Return
+2.03%
1 Year Est. Return
+22.02%
3 Year Est. Return
+59.32%
5 Year Est. Return
+93.99%
10 Year Est. Return
+234.06%
AUM
$129M
AUM Growth
-$5.36M
Cap. Flow
-$7.15M
Cap. Flow %
-5.52%
Top 10 Hldgs %
35.54%
Holding
57
New
1
Increased
Reduced
49
Closed
1

Top Buys

Rank Stock Value
1
UNIT
Uniti Group
UNIT
+$191K

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.54%
3 Industrials 10.48%
4 Financials 9.68%
5 Consumer Discretionary 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
D icon
51
Dominion Energy
D
$60.8B
$247K 0.19%
3,166
BLD
52
DELISTED
TopBuild
BLD
$230K 0.18%
6,364
-2,576
-29% -$87K
UNIT
53
Uniti Group
UNIT
$2.36B
$222K 0.17%
+7,693
New +$191K
PBI icon
54
Pitney Bowes
PBI
$2.4B
$217K 0.17%
12,200
PNY
55
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
$202K 0.16%
3,357
FTR
56
DELISTED
Frontier Communications Corp.
FTR
$133K 0.1%
1,800
TEVA icon
57
Teva Pharmaceuticals
TEVA
$40.8B
-5,790
Closed -$310K

Similar funds

McMillion Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, McMillion Capital Management held 57 positions worth $129M, down 4% from $135M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

McMillion Capital Management withdrew a net $7.15M in Q2 2016, closing 1 position and reducing 49 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $310K position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, McMillion Capital Management opened a new position in Uniti Group worth $222K.

  • McMillion Capital Management's largest Q2 2016 buy was Uniti Group: 7,693 shares worth $222K.
  • McMillion Capital Management's biggest Q2 2016 reduction was Eli Lilly, cutting an estimated $616K.
  • McMillion Capital Management fully exited Teva Pharmaceuticals in Q2 2016, selling an estimated $310K.
  • McMillion Capital Management's ten largest holdings make up 36% of its $129M portfolio in Q2 2016.
  • McMillion Capital Management opened 1 new position and closed 1 in Q2 2016.
  • McMillion Capital Management's portfolio value fell 4% quarter-over-quarter to $129M.

Based on McMillion Capital Management's 13F filing for Q2 2016, filed 9 Aug 2016.